ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
John D. Klemperer
Robert E. Helm
O. Wayne Isom
Karl H. Krieger
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klemperer, J. D.
Right arrow Articles by Krieger, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klemperer, J. D.
Right arrow Articles by Krieger, K. H.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1996;61:1323-1327
© 1996 The Society of Thoracic Surgeons


Original Articles: Cardiovascular

Triiodothyronine Therapy Lowers the Incidence of Atrial Fibrillation After Cardiac Operations

John D. Klemperer, MD, Irwin L. Klein, MD, Kaie Ojamaa, PhD, Robert E. Helm, MD, Maureen Gomez, RN, O. Wayne Isom, MD, Karl H. Krieger, MD

Department of Cardiothoracic Surgery, New York Hospital-Cornell University Medical College, New York, and Department of Medicine, North Shore University Hospital, Manhasset, New York

Background.Cardiopulmonary bypass results in a euthyroid sick state, and recent evidence suggests that perioperative triiodothyronine (T3) supplementation may have hemodynamic benefits. In light of the known effects of thyroid hormone on atrial electrophysiology, we investigated the effects of perioperative T3 supplementation on the incidence of postoperative arrhythmias.

Methods.One hundred forty-two patients with depressed left ventricular function (ejection fraction < 0.40) undergoing coronary artery bypass grafting were randomized to either T3 or placebo treatment groups in a prospective, double-blind fashion. Triiodothyronine was administered as a 0.8 µg/kg intravenous bolus at the time of aortic cross-clamp removal followed by an infusion of 0.113 µg • kg-1 • h-1 for 6 hours. Patients were monitored for the development of arrhythmias during the first 5 postoperative days.

Results.The incidence of sinus tachycardia and ventricular arrhythmias were similar between groups. Triiodothyronine-treated patients had a lower incidence of atrial fibrillation (24% versus 46%; p = 0.009), and fewer required cardioversion (0 versus 6; p = 0.012) or anticoagulation (2 versus 10; p = 0.013) during hospitalization. Six patients in the T3 group versus 16 in the placebo group required antiarrhythmic therapy at discharge (p = 0.019).

Conclusions.Perioperative T3 administration decreased the incidence and need for treatment of postoperative atrial fibrillation.


Related Article

Discussion
Ann. Thorac. Surg. 1996 61: 1328-1329. [Extract] [Full Text]



This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
I. Klein and S. Danzi
Thyroid Hormone Treatment to Mend a Broken Heart
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1172 - 1174.
[Full Text] [PDF]


Home page
Eur Heart JHome page
D. C. Burgess, M. J. Kilborn, and A. C. Keech
Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis
Eur. Heart J., December 1, 2006; 27(23): 2846 - 2857.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. M. Ranasinghe, D. W. Quinn, D. Pagano, N. Edwards, M. Faroqui, T. R. Graham, B. E. Keogh, J. Mascaro, D. W. Riddington, S. J. Rooney, et al.
Glucose-Insulin-Potassium and Tri-Iodothyronine Individually Improve Hemodynamic Performance and Are Associated With Reduced Troponin I Release After On-Pump Coronary Artery Bypass Grafting
Circulation, July 4, 2006; 114(1_suppl): I-245 - I-250.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
A. Ronald and J. Dunning
Does perioperative thyroxine have a role during adult cardiac surgery?
Interactive CardioVascular and Thoracic Surgery, April 1, 2006; 5(2): 166 - 178.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
G. J. Kahaly and W. H. Dillmann
Thyroid Hormone Action in the Heart
Endocr. Rev., August 1, 2005; 26(5): 704 - 728.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. W. Hogue Jr., L. L. Creswell, D. D. Gutterman, and L. A. Fleisher
Epidemiology, Mechanisms, and Risks: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery
Chest, August 1, 2005; 128(2_suppl): 9S - 16S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. Bradley, L. L. Creswell, C. W. Hogue Jr., A. E. Epstein, E. N. Prystowsky, and E. G. Daoud
Pharmacologic Prophylaxis: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery
Chest, August 1, 2005; 128(2_suppl): 39S - 47S.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. G. Cerillo, S. Bevilacqua, S. Storti, M. Mariani, E. Kallushi, A. Ripoli, A. Clerico, and M. Glauber
Free triiodothyronine: a novel predictor of postoperative atrial fibrillation
Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 487 - 492.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
H. Shin, K. Hashizume, Y. Iino, K. Koizumi, T. Matayoshi, and R. Yozu
Effects of atrial fibrillation on coronary artery bypass graft flow
Eur. J. Cardiothorac. Surg., February 1, 2003; 23(2): 175 - 178.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
R. Salenger, J. S. Gammie, and T. J. Vander Salm
Postoperative Care of Cardiac Surgical Patients
Card. Surg. Adult, January 1, 2003; 2(2003): 439 - 469.
[Full Text]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
M. Guden, B. Akpinar, E. Saggbas, I. Sanisoglu, E. Cakali, and O. Bayindir
Effects of Intravenous Triiodothyronine During Coronary Artery Bypass Surgery
Asian Cardiovasc Thorac Ann, September 1, 2002; 10(3): 219 - 222.
[Abstract] [Full Text] [PDF]


Home page
Am J Crit CareHome page
M. Hravnak, L. A. Hoffman, M. I. Saul, T. G. Zullo, and G. R. Whitman
Resource Utilization Related to Atrial Fibrillation After Coronary Artery Bypass Grafting
Am. J. Crit. Care., May 1, 2002; 11(3): 228 - 238.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. M. W. Schmidt, N. Martin, A. C. Georgens, H.-C. Tillmann, M. Feuring, M. Christ, and M. Wehling
Nongenomic Cardiovascular Effects of Triiodothyronine in Euthyroid Male Volunteers
J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1681 - 1686.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
W. H. Maisel, J. D. Rawn, and W. G. Stevenson
Atrial Fibrillation after Cardiac Surgery
Ann Intern Med, December 18, 2001; 135(12): 1061 - 1073.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
I. Klein and K. Ojamaa
Thyroid Hormone and the Cardiovascular System
N. Engl. J. Med., February 15, 2001; 344(7): 501 - 509.
[Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
E. Falkenstein, H.-C. Tillmann, M. Christ, M. Feuring, and M. Wehling
Multiple Actions of Steroid Hormones---A Focus on Rapid, Nongenomic Effects
Pharmacol. Rev., December 1, 2000; 52(4): 513 - 556.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. W. Hogue Jr and M. L. Hyder
Atrial fibrillation after cardiac operation: risks, mechanisms, and treatment
Ann. Thorac. Surg., January 1, 2000; 69(1): 300 - 306.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Guarnieri, S. Nolan, S. O. Gottlieb, A. Dudek, and D. R. Lowry
Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the amiodarone reduction in coronary heart (ARCH) trial
J. Am. Coll. Cardiol., August 1, 1999; 34(2): 343 - 347.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. L. Mullis-Jansson, M. Argenziano, S. Corwin, S. Homma, A. D. Weinberg, M. Williams, E. A. Rose, and C. R. Smith
A RANDOMIZED DOUBLE-BLIND STUDY OF THE EFFECT OF TRIIODOTHYRONINE ON CARDIAC FUNCTION AND MORBIDITY AFTER CORONARY BYPASS SURGERY
J. Thorac. Cardiovasc. Surg., June 1, 1999; 117(6): 1128 - 1135.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
N. Murai, Y. Katayama, T. Yamada, T. Imazeki, Y. Irie, H. Kiyama, Y. Sato, I. Hata, H. Yoshida, and M. Mukouyama
Thyroid Hormone and Myocardial Metabolism After Heart Surgery in Dogs
Asian Cardiovasc Thorac Ann, March 1, 1999; 7(1): 13 - 17.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Walji, R. J. Peterson, P. Neis, R. DuBroff, W. A. Gray, and W. Benge
Ultra-fast track hospital discharge using conventional cardiac surgical techniques
Ann. Thorac. Surg., February 1, 1999; 67(2): 363 - 369.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. A. Ott
Reply
Ann. Thorac. Surg., June 1, 1998; 65(6): 1834 - 1835.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. S. Bietz and R. A. Ott
Rapid Recovery in the Elderly
Ann. Thorac. Surg., October 1, 1997; 64(4): 1222 - 1223.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
R. M. Engelman
Fast-Track Recovery in the Elderly Patient
Ann. Thorac. Surg., March 1, 1997; 63(3): 606 - 607.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
R. A. Ott, D. E. Gutfinger, M. P. Miller, H. Alimadadian, and T. M. Tanner
Rapid Recovery After Coronary Artery Bypass Grafting: Is the Elderly Patient Eligible?
Ann. Thorac. Surg., March 1, 1997; 63(3): 634 - 639.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The Society of Thoracic Surgeons.